Physician profile
Kinga E Styperek
NPI 1215020839
$1,124.40
in general payments reported to CMS, 2019-2025
16 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.28 · 2020: $118 · 2021: $312 · 2022: $248 · 2023: $146 · 2024: $137 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $407.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $313.90 | 2020-2022 | |
| Mentor Worldwide LLC | $216.82 | 2021-2022 | |
| Tela Bio, INC. | $124.54 | 2024 | Ovitex 2s |
| Kowa Pharmaceuticals America, INC. | $84.47 | 2022-2023 | Seglentis |
| Musculoskeletal Transplant Foundation INC. | $70.28 | 2023-2025 | |
| Davol INC. | $44.58 | 2025 | Arista |
| Acera Surgical, INC. | $42.15 | 2023-2025 | Restrata Wound Matrix |
| Merz North America, INC. | $38.36 | 2020-2021 | |
| Amgen INC. | $38.27 | 2019-2020 | |
| Boston Scientific Corporation | $29.84 | 2022 | |
| Cvrx, INC. | $29.06 | 2023 | Barostim Neo System |
| Janssen Pharmaceuticals, INC | $24.74 | 2020 | |
| Tactile Systems Technology INC | $23.93 | 2020 | |
| Bard Peripheral Vascular, INC. | $16.33 | 2023 | |
| Leica Microsystems INC. | $14.47 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $12.66 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kinga Styperek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.